Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC
NCT03806218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2020-04-07
Summary
This study was conducted to provide preliminary data for the main trial to compare efficacy between bipolar radiofrequency ablation (RFA) using twin internally cooled-wet electrodes and switching monopolar RFA using separable clustered electrodes in the treatment of recurrent hepatocellular carcinoma (HCC) after locoregional treatment.
Conditions
Interventions
- DEVICE
-
Bipolar RFA
Bipolar RFA in which RF currents flow between two electrodes
- DEVICE
-
SM-RFA
Monopolar RFA using multiple electrodes with switching mode
- DEVICE
-
Twin internally cooled-wet electrodes
Saline-enhanced twin internally cooled electrodes allow intratumoral injection of a saline solution during the application of the RF current that alters the tissue conductivity
- DEVICE
-
Separable clustered electrodes
A separable clustered electrode is similar to a clustered electrode, although it differs from a conventional clustered electrode in that each individual electrode is separable.
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jeong Min Lee, MD · Seoul National University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-16
- Primary Completion
- 2018-05-16
- Completion
- 2019-02-12
Countries
- South Korea
Study Locations
More Related Trials
-
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
NCT03988998 ·Status: UNKNOWN ·Phase: PHASE3
-
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
NCT01340105 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
NCT00132041 ·Status: COMPLETED ·Phase: NA
-
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
NCT01858207 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
NCT06086002 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma
NCT06682377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes
NCT04471272 ·Status: UNKNOWN ·Phase: NA
-
Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma
NCT00844454 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
NCT05433701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
NCT01833286 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunological Response After Ablative Therapy in the Liver
NCT03040453 ·Status: WITHDRAWN ·Phase: NA
-
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies
NCT02683538 ·Status: COMPLETED ·Phase: PHASE2
-
HR Versus RFA for Early Stage HCC
NCT02169765 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
NCT00554905 ·Status: UNKNOWN ·Phase: PHASE4
-
RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC
NCT02678013 ·Status: UNKNOWN ·Phase: PHASE3
-
RFA Versus SBRT for Recurrent Small HCC
NCT04047173 ·Status: COMPLETED ·Phase: PHASE3
-
Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)
NCT01669668 ·Status: WITHDRAWN ·Phase: PHASE2
-
Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC
NCT02187081 ·Status: UNKNOWN ·Phase: NA
-
Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma
NCT01713244 ·Status: UNKNOWN ·Phase: NA
-
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
NCT03790059 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Microwave and Radiofrequency Ablation for Liver
NCT02539212 ·Status: COMPLETED ·Phase: NA
-
Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma
NCT02646137 ·Status: UNKNOWN ·Phase: PHASE3
-
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
NCT00720668 ·Status: UNKNOWN
-
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
NCT01825824 ·Status: UNKNOWN ·Phase: PHASE2
-
Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma
NCT01570166 ·Status: UNKNOWN ·Phase: NA